HLA-Class II in Latin American patients with type 1 diabetes

Autoimmunity Reviews

Volumn 9, Issue 10, 2010, Pages 666-673

  Rojas Villarraga, Adriana ^a   Botello Corzo, Diana ^a   Anaya, Juan Manuel ^a  

^a UNIVERSIDAD DEL ROSARIO   (Colombia)

Author keywords

HLA; Latin America; Type 1 diabetes

Indexed keywords

GLUTAMATE DECARBOXYLASE; HLA ANTIGEN CLASS 2; HLA DQA1 ANTIGEN; HLA DQB1 ANTIGEN; HLA DR ANTIGEN; PROTEIN TYROSINE PHOSPHATASE;

ANTIGEN BINDING; CASE CONTROL STUDY; DISEASE PREDISPOSITION; GENE FREQUENCY; GENETIC RISK; HAPLOTYPE; HISPANIC; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; NUCLEOTIDE SEQUENCE; PREDICTION; REVIEW; SYSTEMATIC REVIEW;

AUTOANTIGENS; DIABETES MELLITUS, TYPE 1; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GLUTAMATE DECARBOXYLASE; HLA-DR ANTIGENS; HUMANS; LATIN AMERICA; PEPTIDE FRAGMENTS; POLYMORPHISM, GENETIC; PROTEIN BINDING; PROTEIN TYROSINE PHOSPHATASES;

EID: 77955270294     PISSN: 15689972     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.autrev.2010.05.016     Document Type: Review

References (35)

1. Shapira Y., Agmon-Levin N., Shoenfeld Y. Defining and analyzing geoepidemiology and human autoimmunity. J Autoimmun 2010, 34:J168-J177.
2. Anaya J.M., Corena R., Abad V. Type 1 diabetes mellitus at the crossroad of polyautoimmunity. Endocrine Manifestations of Systemic Autoimmune Diseases, Handbook of Systemic Autoimmune Diseases 2008, 211-220. Elsevier Ltd., Johannesburg. S.E. Walker, L.J. Jara (Eds.).
3. Concannon P., Rich S.S., Nepom G.T. Genetics of type 1A diabetes. N Engl J Med 2009, 360:1646-1654.
4. Harrison L.C., Honeyman M.C., Morahan G., Wentworth J.M., Elkassaby S., Colman P.G., et al. Type 1 diabetes: lessons for other autoimmune diseases?. J Autoimmun 2008, 31:306-310.
5. Borchers A.T., Uibo R., Gershwin M.E. The geoepidemiology of type 1 diabetes. Autoimmun Rev 2010, 9:A355-A365.
6. Dorman J.S. Molecular epidemiology of insulin-dependent diabetes mellitus. Epidemiol Rev 1997, 19:91-98.
7. Krause I., Anaya J.M., Fraser A., Barzilai O., Ram M., Abad V., et al. Anti-infectious antibodies and autoimmune-associated autoantibodies in patients with type I diabetes mellitus and their close family members. Ann N Y Acad Sci 2009, 1173:633-639.
8. Anaya J.M., Castiblanco J., Tobón G.J., García J., Abad V., Cuervo H., et al. Familial clustering of autoimmune diseases in patients with type 1 diabetes mellitus. J Autoimmun 2006, 26:208-214.
9. Barrett J.C., Clayton D.G., Concannon P., Akolkar B., Cooper J.D., Erlich H.A., et al. The Type 1 Diabetes Genetics Consortium. Genome-wide association study and meta-analysis find that over 40 loci affect risk of type 1 diabetes. Nat Genet 2009, 41:703-707.
10. Martí L. Diabetes, genética e inmunidad. Medicina (Buenos Aires) 2000, 61:373-375.
11. Thomson G., Valdes A.M., Noble J.A., Kockum I., Grote M.N., Najman J., et al. Relative predispositional effects of HLA class II DRB1-DQB1 haplotypes and genotypes on type 1 diabetes: a meta-analysis. Tissue Antigens 2007, 70:110-127.
12. Erlich H.A., Rotter J.I., Chang J.D., Shaw S.J., Raffel L.J., Klitz W., et al. Association of HLA-DPB1*0301 with IDDM in Mexican-Americans. Diabetes 1996, 45:610-614.
13. Steck A.K., Bugawan T.L., Valdes A.M., Emery L.M., Blair A., Norris J.M., et al. Association of non-HLA genes with type 1 diabetes autoimmunity. Diabetes 2005, 54:2482-2486.
14. Selmi C. The worldwide gradient of autoimmune conditions. Autoimmun Rev 2010, 9:A247-A250.
15. DIAMOND Project Group Incidence and trends of childhood type 1 diabetes worldwide 1990-1999. Diabet Med 2006, 23:857-866.
16. Serrano-Rios M., Goday A., Martinez Larrad T. Migrant populations and the incidence of type 1 diabetes mellitus: an overview of the literature with a focus on the Spanish-heritage countries in Latin America. Diabetes Metab Res Rev 1999, 15:113-132.
17. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diab Care 1997, 20:1183-1197.
18. Alberti K.G., Zimmet P.Z. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 1998, 15:539-553.
19. Mimbacas A., Pérez-Bravo F., Hidalgo P.C., Javiel G., Pisciottano C., Grignola R., et al. Association between diabetes type 1 and DQB1 alleles in a case-control study conducted in Montevideo, Uruguay. Genet Mol Res 2003, 2:29-35.
20. Hauache O.M., Reis A.F., Oliveira C.S., Vieira J.G., Sjöroos M., Ilonen J. Estimation of diabetes risk in Brazilian population by typing for polymorphisms in HLA-DR-DQ, INS and CTLA-4 genes. Dis Markers 2005, 21:139-145.
21. Marques S.B., Volpini W., Caillat-Zucman S., Lieber S.R., Pavin E.J., Persoli L.B. Distribution of HLA-DRB1 alleles in a mixed population with insulin-dependent diabetes mellitus from the southeast of Brazil. Braz J Med Biol Res 1998, 31:365-368.
22. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. National Diabetes Data Group. Diabetes 1979, 28:1039-1057. National Diabetes Data Group.
23. Caputo M., Cerrone G.E., Lopez A.P., Gonzalez C., Mazza C., Cedola N., et al. Genotipificación del gen HLA DQB1 en diabetes autoinmune del adulto (LADA). Medicina (Buenos Aires) 2005, 65:235-240.
24. Gorodezky C., Olivo A., Alaez C., Vázquez M.N., de la Rosa G., Debaz H., et al. High- and low-risk molecular sequences in autoimmune diseases. An analysis of type I diabetes in Latin America. Gac Méd Méx 1997, 133(Suppl 1):125-132.
25. Dorman J.S., McCarthy B., McCanlies E., Kramer M.K., Vergona R.J., Stone R., et al. Molecular IDDM epidemiology: international studies. WHO DiaMond Molecular Epidemiology Sub-Project Group. Diab Res Clin Pract 1996, 34(Suppl):S107-S116.
26. Gorodezky C., Alaez C., Murguía A., Rodríguez A., Balladares S., Vazquez M., et al. HLA and autoimmune diseases: type 1 diabetes (T1D) as an example. Autoimmun Rev 2006, 5:187-194.
27. Levin L., Tomer Y. The etiology of autoimmune diabetes and thyroiditis: evidence for common genetic susceptibility. Autoimmun Rev 2003, 2:377-386.
28. Erlich H., Valdes A.M., Noble J., Carlson J.A., Varney M., Concannon P., et al. Type 1 Diabetes Genetics Consortium. HLA DR-DQ haplotypes and genotypes and type 1 diabetes risk: analysis of the type 1 diabetes genetics consortium families. Diabetes 2008, 57:1084-1092.
29. Santos Martín J.L., Pérez-Bravo F., Carrasco E., Icaza G., Calvillán M., Albala C. Different statistical models used in the calculation of the prevalence of insulin-dependent diabetes mellitus according to the polymorphism of the HLA-DQ region. Immunol Cell Biol 1997, 75:351-355.
30. Parry C.S., Brooks B.R. A new model defines the minimal set of polymorphism in HLA-DQ and -DR that determines susceptibility and resistance to autoimmune diabetes. Biol Direct 2008, 3:42.
31. Temajo N.O., Howard N. The co-operative specificity theory: phenotypic protection from T1D by certain HLA Class II DRB1 and DQ alleles identifies the absence of co-operation between the respective DR and DQ molecules eventuating in no T1D-predisposition. Autoimmun Rev 2009, 8:364-368.
32. Akatsuka H., Yano Y., Gabazza E.C., Morser J., Sasaki R., Suzuki T., et al. A case of fulminant type 1 diabetes with coxsackie B4 virus infection diagnosed by elevated serum levels of neutralizing antibody. Diab Res Clin Pract 2009, 84:e50-e52.
33. Furuya T., Matsumoto I., Tsuchiya N., Hakoda M., Ichikawa N., Yago T., et al. Anti-glucose-6-phosphate isomerase, anti-cyclic citrullinated peptide antibodies and HLA-DRB1 genotypes in Japanese patients with early rheumatoid arthritis. Clin Exp Rheumatol 2008, 26:918-921.
34. Liu J., Purdy L.E., Rabinovitch S., Jevnikar A.M., Elliott J.F. Major DQ8-restricted T-cell epitopes for human GAD65 mapped using human CD4, DQA1*0301, DQB1*0302 transgenic IA(null) NOD mice. Diabetes 1999, 48:469-477.
35. Tabata H., Kanai T., Yoshizumi H., Nishiyama S., Fujimoto S., Matsuda I., et al. Characterization of self-glutamic acid decarboxylase 65-reactive CD4+ T-cell clones established from Japanese patients with insulin-dependent diabetes mellitus. Hum Immunol 1998, 59:549-560.